Variant report
Variant | esv3424240 |
---|---|
Chromosome Location | chr2:211998732-212001480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35733931 | chr2:211998771-211998772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534237361 | chr2:211998785-211998786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182084108 | chr2:211998809-211998810 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558799176 | chr2:211998865-211998866 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572036513 | chr2:211998878-211998879 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187851088 | chr2:211998890-211998891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145980473 | chr2:211998931-211998932 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532776721 | chr2:211998939-211998940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546004516 | chr2:211998952-211998953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200430019 | chr2:211999005-211999006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192321805 | chr2:211999006-211999007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs59333562 | chr2:211999010-211999011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs57551021 | chr2:211999031-211999032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201583048 | chr2:211999037-211999038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544705400 | chr2:211999053-211999054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560646019 | chr2:211999054-211999055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200054206 | chr2:211999085-211999086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185330122 | chr2:211999088-211999089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188346323 | chr2:211999096-211999097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200811563 | chr2:211999140-211999141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs193008132 | chr2:211999169-211999170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201085782 | chr2:211999193-211999194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184661070 | chr2:211999295-211999296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542311718 | chr2:211999299-211999300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530709747 | chr2:211999335-211999336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547913085 | chr2:211999338-211999339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs56851939 | chr2:211999341-211999342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs59235112 | chr2:211999360-211999361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs61215568 | chr2:211999369-211999370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570868153 | chr2:211999383-211999384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60848883 | chr2:211999384-211999385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58109294 | chr2:211999390-211999391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs57570552 | chr2:211999403-211999404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs60749825 | chr2:211999417-211999418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs60999864 | chr2:211999419-211999420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs61425006 | chr2:211999425-211999426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs59867992 | chr2:211999430-211999431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61722033 | chr2:211999444-211999445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61723889 | chr2:211999458-211999459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62652062 | chr2:211999463-211999464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376133815 | chr2:211999474-211999475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368289189 | chr2:211999481-211999482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564815887 | chr2:211999518-211999519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374577649 | chr2:211999519-211999520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539596155 | chr2:211999543-211999544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556416124 | chr2:211999544-211999545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180947306 | chr2:211999552-211999553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557528923 | chr2:211999573-211999574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569931696 | chr2:211999577-211999578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372500476 | chr2:211999581-211999582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 21346763 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:211994600-211998800 | Enhancers | Hela-S3 | cervix |
2 | chr2:211996400-211998800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:211996400-211998800 | Enhancers | HSMM | muscle |
4 | chr2:211996600-211998800 | Enhancers | NH-A | brain |
5 | chr2:211996800-211998800 | Enhancers | HMEC | breast |
6 | chr2:211996800-211998800 | Enhancers | HUVEC | blood vessel |
7 | chr2:211996800-211999000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr2:211996800-211999000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr2:211997000-211998800 | Enhancers | HSMMtube | muscle |
10 | chr2:211997000-211998800 | Enhancers | NHEK | skin |
11 | chr2:211997000-211998800 | Enhancers | Osteobl | bone |
12 | chr2:211997400-211998800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr2:211997400-211998800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr2:211997600-211998800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr2:211998200-211998800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr2:211998600-211998800 | Enhancers | Pancreas | Pancrea |
17 | chr2:211998800-212004600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr2:211998800-212009400 | Weak transcription | HSMM | muscle |